indications for glp-1 There are numerous actions throughout the body. There is an ever-growing list of established GLP-1 based medications. And an even more rapid expanding list of investigations… GLP-1 Receptor Agonists | New

SGLT2 inhibitors offer particular benefits in heart failure (HF) and CKD, while GLP-1 RAs are particularly effective in reducing ischemic events and weight loss, with improvement in metabolic parameters

These populations already face elevated bone loss risk, and adding GLP-1 therapy without calcium and vitamin D supplementation multiplies that risk substantially

Visualization: RGL, ETF, LMPG

But the response to any given dose varies substantially based on individual factors

Some pharmacies carry it, but stock fluctuates significantly

The analysis included eight randomized controlled trials with 2,372 participants (all with BMI 27 kg/m) and found that weight regain was proportional to the amount initially lost.48 On average, participants who had taken liraglutide regained 2.2 kg, while those who had taken semaglutide or tirzepatide regained 9.69 kg after stopping the medication.48 Similarly, a 2025 review in Biomolecules showed that patients treated with GLP-1 or dual GLP-1/GIP agonists experience substantial weight loss (ranging from about 6% to over 20%) but also significant weight regain upon drug discontinuation